Gobi Capital LLC Has $120.15 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Gobi Capital LLC raised its position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 25.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 443,882 shares of the company’s stock after purchasing an additional 89,766 shares during the quarter. HCA Healthcare accounts for approximately 8.7% of Gobi Capital LLC’s holdings, making the stock its 6th biggest position. Gobi Capital LLC owned about 0.17% of HCA Healthcare worth $120,150,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Norges Bank purchased a new position in shares of HCA Healthcare during the 4th quarter valued at about $694,985,000. Royal Bank of Canada lifted its holdings in HCA Healthcare by 35.7% in the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock worth $1,219,121,000 after purchasing an additional 1,183,890 shares in the last quarter. Capital World Investors lifted its holdings in HCA Healthcare by 112.1% in the 4th quarter. Capital World Investors now owns 1,772,627 shares of the company’s stock worth $479,815,000 after purchasing an additional 936,823 shares in the last quarter. Sanders Capital LLC lifted its holdings in HCA Healthcare by 4.2% in the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after purchasing an additional 456,738 shares in the last quarter. Finally, TD Asset Management Inc lifted its holdings in HCA Healthcare by 230.5% in the 4th quarter. TD Asset Management Inc now owns 553,225 shares of the company’s stock worth $149,747,000 after purchasing an additional 385,854 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the transaction, the executive vice president now owns 34,124 shares in the company, valued at $10,544,316. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the firm’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the sale, the executive vice president now owns 34,124 shares of the company’s stock, valued at $10,544,316. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Chad J. Wasserman sold 876 shares of the firm’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total value of $289,299.00. Following the sale, the senior vice president now directly owns 1,576 shares of the company’s stock, valued at approximately $520,474. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,617 shares of company stock worth $4,321,986. 1.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several analysts have recently issued reports on HCA shares. Oppenheimer upped their price objective on HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a report on Monday, April 29th. StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 8th. Barclays boosted their target price on HCA Healthcare from $356.00 to $367.00 and gave the company an “overweight” rating in a research report on Monday, April 29th. Robert W. Baird initiated coverage on HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a research report on Friday, April 12th. Four research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $325.59.

Read Our Latest Stock Report on HCA Healthcare

HCA Healthcare Price Performance

HCA traded down $0.99 during trading on Thursday, hitting $339.82. The company’s stock had a trading volume of 230,630 shares, compared to its average volume of 1,068,129. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $343.53. The business’s fifty day simple moving average is $320.11 and its 200 day simple moving average is $311.89. The firm has a market capitalization of $89.00 billion, a price-to-earnings ratio of 16.89, a P/E/G ratio of 1.58 and a beta of 1.69.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, beating the consensus estimate of $5.01 by $0.35. The company had revenue of $17.34 billion for the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. HCA Healthcare’s quarterly revenue was up 11.2% compared to the same quarter last year. During the same period last year, the company earned $4.93 earnings per share. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 20.92 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be given a $0.66 dividend. The ex-dividend date is Friday, June 14th. This represents a $2.64 annualized dividend and a dividend yield of 0.78%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.